<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2026-17-1-20-26</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-2165</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАРДИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>Цитокиновый профиль пациентов с ишемической болезнью сердца при стентировании коронарных артерий: влияние психоэмоционального статуса</article-title><trans-title-group xml:lang="en"><trans-title>Cytokine profile of patients with coronary artery disease undergoing coronary artery stenting: the influence of psychoemotional status</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5599-0166</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орехова</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Orekhova</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орехова Юлия Николаевна, врач-кардиолог</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Yuliya N. Orekhova, cardiologist</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">orehowa.yulia@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-9385-2573</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванченко</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanchenko</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванченко Дарья Николаевна, к.м.н., доцент кафедры терапии; заместитель главного врача по медицинской части</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Darya N. Ivanchenko, Cand. Sci. (Med.), Assotiate Professor of the Department of Therapy; Deputy Chief Physitian for Medical Affairs</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">d_ivanchenko@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-2046-7526</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дорофеева</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Dorofeeva</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дорофеева Наталья Петровна, д.м.н., профессор кафедры терапии; заведующая кардиологическим отделением</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Natalya P. Dorofeeva, Dr. Sci. (Med.), Professor of the Department of Therapy; Head of the Cardology Department</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">ppmahogany@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Ростовская клиническая больница Южного окружного медицинского центра ФМБА России<country>Россия</country></aff><aff xml:lang="en">Rostov Clinical Hospital, Southern District Medical Center, FMBA of Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Ростовский государственный медицинский университет; Ростовская клиническая больница Южного окружного медицинского центра ФМБА России<country>Россия</country></aff><aff xml:lang="en">Rostov State Medical Unoversity; Rostov Clinical Hospital, Southern District Medical Center, FMBA of Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>26</day><month>03</month><year>2026</year></pub-date><volume>17</volume><issue>1</issue><fpage>20</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Орехова Ю.Н., Иванченко Д.Н., Дорофеева Н.П., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Орехова Ю.Н., Иванченко Д.Н., Дорофеева Н.П.</copyright-holder><copyright-holder xml:lang="en">Orekhova Y.N., Ivanchenko D.N., Dorofeeva N.P.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/2165">https://www.medicalherald.ru/jour/article/view/2165</self-uri><abstract><p>Цель: изучить влияние коронарного стентирования на уровень цитокинов у пациентов со стабильной ишемической болезнью сердца (ИБС), проанализировать особенности цитокинового статуса до и после стентирования в зависимости от развития неблагоприятных исходов в течение года после вмешательства, оценить вклад изменений эмоционального статуса в динамику уровня цитокинов. Материалы и методы: в исследование были включены 58 пациентов со стабильной ИБС, госпитализированных для проведения транслюминальной баллонной ангиопластики (ТЛБАП) со стентированием в плановом порядке. Определяли уровни интерферона-γ (ИФН-γ), интерлейкина-17 (ИЛ-17), интерлейкина-6 (ИЛ-6), интерлейкина-4 (ИЛ-4), фактора некроза опухолей-α (ФНО-α) исходно и на третьи сутки от момента проведения вмешательства. Проводилось психометрическое тестирование с использованием опросников CES-D и HADS. Результаты: отклонения эмоционального статуса, согласно результатам психометрического тестирования, отмечались у 20,68% пациентов при клинической сопоставимости групп. Их наличие сопровождалось исходно более высоким уровнем ИЛ-6. Проведение процедуры стентирования приводило к нарастанию провоспалительного потенциала, что отражалось в повышении уровней ИЛ-17 и ФНО-α при отсутствии динамики уровня ИЛ-4. Выявление показателей депрессии по шкале CES-D ассоциировалось со значимым повышением уровней ИЛ-6 и ИФН-γ в послеоперационном периоде. Более высокий уровень ИЛ-17 как до, так и после стентирования и ИЛ-6 после стентирования ассоциировались с развитием неблагоприятных исходов.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to investigate the influence of percutaneous coronary intervention (PCI) on cytokine levels in patients with stable IHD, to analyze the features of cytokine status before and after PCI, depending on the development of adverse outcomes within a year after the intervention, and to assess the influence of emotional state changes at cytokine level. Materials and methods: 58 patients with stable IHD hospitalized for PCI were included into the study. The levels of IFN-γ, IL-17, IL-6, IL-4, TNF-α were measured initially and on the third day after the intervention. Psychometric testing was carried out using the CES-D and HADS questionnaires. Results: according to psychometric testing results, 20.7% of patients had emotional state changes. Groups of patients were comparable by clinical features. The presence of emotional disturbances was complemented by an increase in the level of IL-6. PCI was accompanied by an increase in proinflammatory potential, which was reflected in an increase in IL-17 and TNF-α levels in the absence of IL-4 level dynamics. The presence of depression’s indicators (by using CES-D scale) was associated with a significant increase in IL-6 and IFN-γ levels on the third day after PCI. A higher level of IL- 17 both before and after stenting and IL-6 after stenting was associated with the development of adverse outcomes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>эмоциональный статус</kwd><kwd>воспаление</kwd><kwd>цитокины</kwd><kwd>чрескожные коронарные вмешательства</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ischemic heart disease</kwd><kwd>emotional state</kwd><kwd>inflammation</kwd><kwd>cytokines</kwd><kwd>percutaneous coronary interventions</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Donisan T, Madanat L, Balanescu DV, Mertens A, Dixon S. Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge. Curr Cardiol Rev. 2023;19(3):e030123212355. https://doi.org/10.2174/1573403X19666230103154638</mixed-citation><mixed-citation xml:lang="en">Donisan T, Madanat L, Balanescu DV, Mertens A, Dixon S. Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge. Curr Cardiol Rev. 2023;19(3):e030123212355. https://doi.org/10.2174/1573403X19666230103154638</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rus M, Sava CN, Ardelean AI, Pasca G, Andronie-Cioara FL, et al. Exploring the Connection Between Depression, Inflammatory Biomarkers, and Atherosclerotic Coronary Artery Disease. J Clin Med. 2025;14(9):2946. https://doi.org/10.3390/jcm14092946</mixed-citation><mixed-citation xml:lang="en">Rus M, Sava CN, Ardelean AI, Pasca G, Andronie-Cioara FL, et al. Exploring the Connection Between Depression, Inflammatory Biomarkers, and Atherosclerotic Coronary Artery Disease. J Clin Med. 2025;14(9):2946. https://doi.org/10.3390/jcm14092946</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sălcudean A, Bodo CR, Popovici RA, Cozma MM, Păcurar M, et al. Neuroinflammation-A Crucial Factor in the Pathophysiology of Depression-A Comprehensive Review. Biomolecules. 2025;15(4):502. https://doi.org/10.3390/biom15040502</mixed-citation><mixed-citation xml:lang="en">Sălcudean A, Bodo CR, Popovici RA, Cozma MM, Păcurar M, et al. Neuroinflammation-A Crucial Factor in the Pathophysiology of Depression-A Comprehensive Review. Biomolecules. 2025;15(4):502. https://doi.org/10.3390/biom15040502</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Максимова Н.М., Булгакова Т.С., Узбеков М.Г. Роль цитокинов в патогенезе и терапии психических расстройств. Социальная и клиническая психиатрия. 2019;29(3):71-77. eLIBRARY ID: 41137059 EDN: KNZWJS</mixed-citation><mixed-citation xml:lang="en">Maximova N.M., Bulgakova T.S., Uzbekov M.G. The role of cytokines in pathogenesis and therapy of mental disorders. Social and clinical psychiatry. 2019;29(3):71-77. (In Russ.) eLIBRARY ID: 41137059 EDN: KNZWJS</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lu H, Yang Q, Zhang Y. The relation of common inflammatory cytokines with anxiety and depression and their values in estimating cardiovascular outcomes in coronary heart disease patients. J Clin Lab Anal. 2022;36(6):e24404. https://doi.org/10.1002/jcla.24404</mixed-citation><mixed-citation xml:lang="en">Lu H, Yang Q, Zhang Y. The relation of common inflammatory cytokines with anxiety and depression and their values in estimating cardiovascular outcomes in coronary heart disease patients. J Clin Lab Anal. 2022;36(6):e24404. https://doi.org/10.1002/jcla.24404</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Min X, Lu M, Tu S, Wang X, Zhou C, et al. Serum Cytokine Profile in Relation to the Severity of Coronary Artery Disease. Biomed Res Int. 2017;2017:4013685. https://doi.org/10.1155/2017/4013685</mixed-citation><mixed-citation xml:lang="en">Min X, Lu M, Tu S, Wang X, Zhou C, et al. Serum Cytokine Profile in Relation to the Severity of Coronary Artery Disease. Biomed Res Int. 2017;2017:4013685. https://doi.org/10.1155/2017/4013685</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sun J, Yu H, Liu H, Pu D, Gao J, et al. Correlation of preoperative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents. J Clin Lab Anal. 2020;34(3):e23108. https://doi.org/10.1002/jcla.23108</mixed-citation><mixed-citation xml:lang="en">Sun J, Yu H, Liu H, Pu D, Gao J, et al. Correlation of preoperative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents. J Clin Lab Anal. 2020;34(3):e23108. https://doi.org/10.1002/jcla.23108</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gędek A, Modrzejewski S, Materna M, Iwański M, Wichniak A, Dominiak M. Altered cytokine levels in the first episode of major depression and in antidepressant-naïve patients: a systematic review and meta-analysis Int. J. Mol. Sci. 2025;26:10362. https://doi.org/10.3390/ijms262110362</mixed-citation><mixed-citation xml:lang="en">Gędek A, Modrzejewski S, Materna M, Iwański M, Wichniak A, Dominiak M. Altered cytokine levels in the first episode of major depression and in antidepressant-naïve patients: a systematic review and meta-analysis Int. J. Mol. Sci. 2025;26:10362. https://doi.org/10.3390/ijms262110362</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Закирова Н.Е., Хафизов Н.Х., Карамова И.М., Закирова А.Н., Оганов Р.Г. Иммуновоспалительные реакции при ишемической болезни сердца. Рациональная фармакотерапия в кардиологии. 2007;3(2):16-19 eLIBRARY ID: 11516274 EDN: JSAHCD</mixed-citation><mixed-citation xml:lang="en">Zakirova N.E., Khafizov N.Kh., Karamova I.M., Zakirova A.N., Oganov R.G. Immuno-inflamatory response in ischemic heart disease. Rational’naya farmakoterapiya v kardiologii. 2007;3(2):16-19. (In Russ.) eLIBRARY ID: 11516274 EDN: JSAHCD</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171-186. https://doi.org/10.1097/PSY.0b013e3181907c1b</mixed-citation><mixed-citation xml:lang="en">Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171-186. https://doi.org/10.1097/PSY.0b013e3181907c1b</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">H ot A, Lenief V, Miossec P. Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis. 2012;71(5):768-776. https://doi.org/10.1136/annrheumdis-2011-200468</mixed-citation><mixed-citation xml:lang="en">Hot A, Lenief V, Miossec P. Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis. 2012;71(5):768-776. https://doi.org/10.1136/annrheumdis-2011-200468</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gao W, Gao Y, Xu Y, Liang J, Sun Y, et al. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder. BMC Psychiatry. 2024;24(1):449. https://doi.org/10.1186/s12888-024-05910-0</mixed-citation><mixed-citation xml:lang="en">Gao W, Gao Y, Xu Y, Liang J, Sun Y, et al. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder. BMC Psychiatry. 2024;24(1):449. https://doi.org/10.1186/s12888-024-05910-0</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wachholz S, Knorr A, Mengert L, Plümper J, Sommer R, et al. Interleukin-4 is a participant in the regulation of depressivelike behavior. Behav Brain Res. 2017;326:165-172. https://doi.org/10.1016/j.bbr.2017.03.020</mixed-citation><mixed-citation xml:lang="en">Wachholz S, Knorr A, Mengert L, Plümper J, Sommer R, et al. Interleukin-4 is a participant in the regulation of depressivelike behavior. Behav Brain Res. 2017;326:165-172. https://doi.org/10.1016/j.bbr.2017.03.020</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
